Alexandra Kropotova - 11 Dec 2025 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF MEDICAL OFFICER
Signature
Alexandra Kropotova
Issuer symbol
SABS
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
4
Filing time
12 Dec 2025, 16:45:02 UTC
Previous filing
24 Nov 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kropotova Alexandra CHIEF MEDICAL OFFICER 777 W 41ST, SUITE 401, MIAMI BEACH Alexandra Kropotova 12 Dec 2025 0001825323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -988 -2.2% 44,284 11 Dec 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units ("RSUs").
F2 Includes 31,946 shares of Common Stock and 12,338 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.